Cargando…

LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types

BACKGROUND: The relative contribution of epigenetic mechanisms to carcinogenesis is not well understood, including the extent to which epigenetic dysregulation and somatic mutations target similar genes and pathways. We hypothesize that during carcinogenesis, certain pathways or biological gene sets...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jung H, Karnovsky, Alla, Mahavisno, Vasudeva, Weymouth, Terry, Pande, Manjusha, Dolinoy, Dana C, Rozek, Laura S, Sartor, Maureen A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505188/
https://www.ncbi.nlm.nih.gov/pubmed/23033966
http://dx.doi.org/10.1186/1471-2164-13-526
_version_ 1782250728758181888
author Kim, Jung H
Karnovsky, Alla
Mahavisno, Vasudeva
Weymouth, Terry
Pande, Manjusha
Dolinoy, Dana C
Rozek, Laura S
Sartor, Maureen A
author_facet Kim, Jung H
Karnovsky, Alla
Mahavisno, Vasudeva
Weymouth, Terry
Pande, Manjusha
Dolinoy, Dana C
Rozek, Laura S
Sartor, Maureen A
author_sort Kim, Jung H
collection PubMed
description BACKGROUND: The relative contribution of epigenetic mechanisms to carcinogenesis is not well understood, including the extent to which epigenetic dysregulation and somatic mutations target similar genes and pathways. We hypothesize that during carcinogenesis, certain pathways or biological gene sets are commonly dysregulated via DNA methylation across cancer types. The ability of our logistic regression-based gene set enrichment method to implicate important biological pathways in high-throughput data is well established. RESULTS: We developed a web-based gene set enrichment application called LRpath with clustering functionality that allows for identification and comparison of pathway signatures across multiple studies. Here, we employed LRpath analysis to unravel the commonly altered pathways and other gene sets across ten cancer studies employing DNA methylation data profiled with the Illumina HumanMethylation27 BeadChip. We observed a surprising level of concordance in differential methylation across multiple cancer types. For example, among commonly hypomethylated groups, we identified immune-related functions, peptidase activity, and epidermis/keratinocyte development and differentiation. Commonly hypermethylated groups included homeobox and other DNA-binding genes, nervous system and embryonic development, and voltage-gated potassium channels. For many gene sets, we observed significant overlap in the specific subset of differentially methylated genes. Interestingly, fewer DNA repair genes were differentially methylated than expected by chance. CONCLUSIONS: Clustering analysis performed with LRpath revealed tightly clustered concepts enriched for differential methylation. Several well-known cancer-related pathways were significantly affected, while others were depleted in differential methylation. We conclude that DNA methylation changes in cancer tend to target a subset of the known cancer pathways affected by genetic aberrations.
format Online
Article
Text
id pubmed-3505188
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35051882012-11-24 LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types Kim, Jung H Karnovsky, Alla Mahavisno, Vasudeva Weymouth, Terry Pande, Manjusha Dolinoy, Dana C Rozek, Laura S Sartor, Maureen A BMC Genomics Research Article BACKGROUND: The relative contribution of epigenetic mechanisms to carcinogenesis is not well understood, including the extent to which epigenetic dysregulation and somatic mutations target similar genes and pathways. We hypothesize that during carcinogenesis, certain pathways or biological gene sets are commonly dysregulated via DNA methylation across cancer types. The ability of our logistic regression-based gene set enrichment method to implicate important biological pathways in high-throughput data is well established. RESULTS: We developed a web-based gene set enrichment application called LRpath with clustering functionality that allows for identification and comparison of pathway signatures across multiple studies. Here, we employed LRpath analysis to unravel the commonly altered pathways and other gene sets across ten cancer studies employing DNA methylation data profiled with the Illumina HumanMethylation27 BeadChip. We observed a surprising level of concordance in differential methylation across multiple cancer types. For example, among commonly hypomethylated groups, we identified immune-related functions, peptidase activity, and epidermis/keratinocyte development and differentiation. Commonly hypermethylated groups included homeobox and other DNA-binding genes, nervous system and embryonic development, and voltage-gated potassium channels. For many gene sets, we observed significant overlap in the specific subset of differentially methylated genes. Interestingly, fewer DNA repair genes were differentially methylated than expected by chance. CONCLUSIONS: Clustering analysis performed with LRpath revealed tightly clustered concepts enriched for differential methylation. Several well-known cancer-related pathways were significantly affected, while others were depleted in differential methylation. We conclude that DNA methylation changes in cancer tend to target a subset of the known cancer pathways affected by genetic aberrations. BioMed Central 2012-10-04 /pmc/articles/PMC3505188/ /pubmed/23033966 http://dx.doi.org/10.1186/1471-2164-13-526 Text en Copyright ©2012 Kim et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kim, Jung H
Karnovsky, Alla
Mahavisno, Vasudeva
Weymouth, Terry
Pande, Manjusha
Dolinoy, Dana C
Rozek, Laura S
Sartor, Maureen A
LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types
title LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types
title_full LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types
title_fullStr LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types
title_full_unstemmed LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types
title_short LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types
title_sort lrpath analysis reveals common pathways dysregulated via dna methylation across cancer types
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505188/
https://www.ncbi.nlm.nih.gov/pubmed/23033966
http://dx.doi.org/10.1186/1471-2164-13-526
work_keys_str_mv AT kimjungh lrpathanalysisrevealscommonpathwaysdysregulatedviadnamethylationacrosscancertypes
AT karnovskyalla lrpathanalysisrevealscommonpathwaysdysregulatedviadnamethylationacrosscancertypes
AT mahavisnovasudeva lrpathanalysisrevealscommonpathwaysdysregulatedviadnamethylationacrosscancertypes
AT weymouthterry lrpathanalysisrevealscommonpathwaysdysregulatedviadnamethylationacrosscancertypes
AT pandemanjusha lrpathanalysisrevealscommonpathwaysdysregulatedviadnamethylationacrosscancertypes
AT dolinoydanac lrpathanalysisrevealscommonpathwaysdysregulatedviadnamethylationacrosscancertypes
AT rozeklauras lrpathanalysisrevealscommonpathwaysdysregulatedviadnamethylationacrosscancertypes
AT sartormaureena lrpathanalysisrevealscommonpathwaysdysregulatedviadnamethylationacrosscancertypes